Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Gadolinium contrast agents - Important Safety Information from Bayer Ltd, Bracco Imaging S.p.A, GE Healthcare Ltd and Guerbet as approved by the HPRA
Notice type:
3rd Party Publications
Date:
12/12/2017
Problem Or Issue:
Important Safety Information communication from Bayer Ltd, Bracco Imaging S.p.A, GE Healthcare Ltd and Guerbet on gadolinium contrast agents: updated recommendations following review of gadolinium retention in brain and other tissues.
Important Safety Information - Gadolinium contrast agents
« Back
Date Printed: 26/04/2024